{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.602","meta":{"versionId":"12","lastUpdated":"2021-03-06T01:00:21.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602","version":"20210306","name":"Neurokinin 1 Receptor Antagonist","status":"active","date":"2021-03-06T01:00:21-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.144"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.145"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.147"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.146"]}]},"expansion":{"identifier":"urn:uuid:d56c0f15-b56f-48a2-bc9e-d2e144b31108","timestamp":"2022-06-10T10:04:22-04:00","total":13,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1552343","display":"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1665503","display":"rolapitant 90 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1729308","display":"aprepitant 125 MG Powder for Oral Suspension"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1731075","display":"fosaprepitant 115 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1731077","display":"fosaprepitant 150 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1986885","display":"92.5 ML rolapitant 1.8 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1995150","display":"18 ML aprepitant 7.2 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2044429","display":"fosnetupitant 235 MG / palonosetron 0.25 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2374366","display":"20 ML fosnetupitant 11.75 MG/ML / palonosetron 0.0125 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"403810","display":"aprepitant 80 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"403811","display":"aprepitant 125 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"644088","display":"aprepitant 40 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"754508","display":"{1 (aprepitant 125 MG Oral Capsule) / 2 (aprepitant 80 MG Oral Capsule) } Pack"}]}}